Cargando…

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending

Detalles Bibliográficos
Autores principales: Huang, Tao, Wagner, Anita Katharina, Bai, Lin, Huang, Cong, Guan, Xiaodong, Shi, Luwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045901/
https://www.ncbi.nlm.nih.gov/pubmed/33609064
http://dx.doi.org/10.1002/cac2.12144
_version_ 1783678747585544192
author Huang, Tao
Wagner, Anita Katharina
Bai, Lin
Huang, Cong
Guan, Xiaodong
Shi, Luwen
author_facet Huang, Tao
Wagner, Anita Katharina
Bai, Lin
Huang, Cong
Guan, Xiaodong
Shi, Luwen
author_sort Huang, Tao
collection PubMed
description
format Online
Article
Text
id pubmed-8045901
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80459012021-04-16 Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending Huang, Tao Wagner, Anita Katharina Bai, Lin Huang, Cong Guan, Xiaodong Shi, Luwen Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2021-02-20 /pmc/articles/PMC8045901/ /pubmed/33609064 http://dx.doi.org/10.1002/cac2.12144 Text en © 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Huang, Tao
Wagner, Anita Katharina
Bai, Lin
Huang, Cong
Guan, Xiaodong
Shi, Luwen
Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
title Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
title_full Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
title_fullStr Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
title_full_unstemmed Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
title_short Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
title_sort anticancer medicines in china: trends in daily therapy cost and relative procurement volume and spending
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045901/
https://www.ncbi.nlm.nih.gov/pubmed/33609064
http://dx.doi.org/10.1002/cac2.12144
work_keys_str_mv AT huangtao anticancermedicinesinchinatrendsindailytherapycostandrelativeprocurementvolumeandspending
AT wagneranitakatharina anticancermedicinesinchinatrendsindailytherapycostandrelativeprocurementvolumeandspending
AT bailin anticancermedicinesinchinatrendsindailytherapycostandrelativeprocurementvolumeandspending
AT huangcong anticancermedicinesinchinatrendsindailytherapycostandrelativeprocurementvolumeandspending
AT guanxiaodong anticancermedicinesinchinatrendsindailytherapycostandrelativeprocurementvolumeandspending
AT shiluwen anticancermedicinesinchinatrendsindailytherapycostandrelativeprocurementvolumeandspending